Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Moderna, Inc.(MRNA) | 2,308,190 | 2,308,190 | 0 | $161.64M | $444.49M | 54.18% | +$282.85M |
| Personalis, Inc.(PSNL) | 14,044,943 | 14,044,943 | 0 | $188.20M | $228.65M | 27.87% | +$40.45M |
| Kymera Therapeutics, Inc.(KYMR) | 772,165 | 772,165 | 0 | $88.54M | $86.32M | 10.52% | -$2.22M |
| Aktis Oncology, Inc.(AKTS) | 952,844 | 952,844 | 0 | $30.71M | $18.55M | 2.26% | -$12.16M |
| Eikon Therapeutics Inc | 1,666,666 | 1,666,666 | 0 | $21.75M | $13.40M | 1.63% | -$8.35M |
| Entrada Therapeutics Inc | 1,739,768 | 1,739,768 | 0 | $12.80M | $11.05M | 1.35% | -$1.76M |
| Alector Inc | 3,545,719 | 3,545,719 | 0 | $7.13M | $6.56M | 0.80% | -$567.3K |
| Sutro Biopharma Inc | 272,351 | 272,351 | 0 | $9.04M | $4.39M | 0.53% | -$4.65M |
| Evaxion AsADS | 1,214,126 | 1,214,126 | 0 | $3.76M | $3.98M | 0.49% | +$218.5K |
| Viridian Therapeutics, Inc.(VRDN) | 93,414 | 93,414 | 0 | $1.72M | $1.92M | 0.23% | +$207.4K |
| Xilio Therapeutics Inc | 105,982 | 105,982 | 0 | $1.02M | $959.1K | 0.12% | -$56.2K |
| Tuhura Biosciences Inc | 19,445 | 19,445 | 0 | $45.5K | $40.8K | 0.00% | -$4.7K |
| Neuphoria Therapeutics Inc | 10,027 | 10,027 | 0 | $43.8K | $35.7K | 0.00% | -$8.1K |